Please be advised of the need to be vigilant when co-prescribing opiates and tricyclic anti-depressants, especially Oxycodone and Amitriptyline, in view of the risk of over-sedation. Extra caution is advised in patients who have underlying respiratory conditions.
Latest News
Vision has implemented "High Risk" similar drug name warnings to meet requirements and in response to a MHRA drug safety update and ISMP safety alert.
We have been made aware of a potential issue in relation to the use of the Last Run reporting feature available within the Vision+ application. It is possible to add an entry to the record of a patient included within a Last Run report.